What is NA-Semax Amidate?
NA-Semax Amidate describes a Semax variant with terminal modifications. The selected laboratory publication examined acetylated Semax, but does not verify the complete marketed acetylated-and-amidated variant.
Biological role or research focus
Modified-Semax identity and evidence limits.
The tested acetylated compound is related evidence, not confirmation of the full amidated variant or human cognitive benefit.
Names you may encounter
N-Acetyl Semax Amidate · NA Semax amidate
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- N-acetylated, C-terminal-amidated Semax variant label
- Research focus
- Modified-Semax identity and evidence limits
- Featured evidence
- Related modification · Chemical and cell study
- Source check
- October 4, 2026
Quick answers
- Is NA-Semax Amidate FDA approved?
- No. No FDA-approved drug contains NA-Semax Amidate. Source ↗
- Is NA-Semax Amidate safe?
- Unapproved modified form of Semax with no published human safety studies; evidence is limited to chemistry and cell experiments. Human safety data: none. The Risks & interactions section below lists what is known. Read the risks ↓
- Is NA-Semax Amidate banned in sport?
- Very likely. The 2026 World Anti-Doping Agency (WADA) Prohibited List does not name it, but it appears to fall under a banned class (S0 Non-approved substances). Source ↗
What does the evidence show?
Evidence map
Every study featured on this page, grouped by what was actually tested. Human studies count most; animal and cell results often do not carry over to people.
| Study | Type | Population / model |
|---|---|---|
| Acetylated Semax metal-complex experiments (2016) | Chemical systems and SH-SY5Y cells. |
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Related modification · Chemical and cell study · 2016
Acetylated Semax metal-complex experiments
What did this publication test, and what did it find?
- Population / model
- Chemical systems and SH-SY5Y cells.
- Study design
- Comparison of Semax-related metal complexes and cellular toxicity or ion-response measurements.
- Main finding
- Acetylation changed the metal-complex context but did not protect against copper-associated toxicity in the tested cells. Zinc-related cellular responses were also examined.
- Limits & context
- The tested acetylated compound is related evidence, not confirmation of the full amidated variant or human cognitive benefit.
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Registered human trials
No study naming NA-Semax Amidate as an intervention was found on ClinicalTrials.gov when we last checked (November 16, 2026). That means no registered human trial, not proof that none has ever been done elsewhere.
Further reading · 0 additional publication links
Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.
No additional records were returned by this limited exact-name search. That is not evidence that no research exists; alternative scientific names may need investigation.
Repeat this PubMed search ↗Risks & interactions
Unapproved modified form of Semax with no published human safety studies; evidence is limited to chemistry and cell experiments.
No human studies of this modified form were found. A chemistry and cell study of acetylated Semax is the main related evidence, and FDA listed parent Semax among compounding substances with limited safety information.
Unassessed: no human safety data
It isn't approved, so there is no official list of who should avoid it, and no human safety studies have been published. No condition is tagged, but that does not make it safe for anyone. If a condition applies to you, talk to a doctor or pharmacist first.
Who should not use it
There is no official list, because it has never been approved as a medicine. That is not a sign it is safe for anyone: its risks have not been studied enough to know who is most at risk.
Summarized from published studies with AI assistance; not reviewed by a clinician. Not a complete list, and not medical advice: talk to a doctor or pharmacist about your own situation. Checked 2026-10-10. Sources: N-terminus acetylation of Semax: metal binding and cell effects (2016) ↗ · FDA: Bulk drug substances that may present significant safety risks ↗
Safety & what remains unknown
Cell experiments cannot define systemic safety; incomplete variant evidence should not be interpreted as reassurance.
Evidence boundaries
The tested acetylated compound is related evidence, not confirmation of the full amidated variant or human cognitive benefit.
Regulatory status
- U.S. FDA approval
- Not approved
No FDA-approved drug containing this substance found in Drugs@FDA (openFDA data updated 2026-10-07). source - FDA compounding (503A bulk list)
- Not on FDA’s compounding lists
Not found on FDA's 503A category 1, 2 or 3 lists (updated May 14, 2026) or the category 2 safety-risk page (updated April 22, 2026). source - World Anti-Doping Agency (2026)
- Likely prohibited under a class rule · S0 Non-approved substances
Not named. S0 prohibits (at all times) any pharmacological substance not covered by another section and with no current approval by any government health authority for human therapeutic use; no such approval was found, so it is likely covered. source
Checked October 28, 2026. Rules change; follow the source links for the current status. Regulatory tracker.
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
Research context & identity
Parent Semax, acetylated Semax, and an acetylated-and-amidated variant should remain distinct interventions. No exact-variant human clinical study was verified for this page.
New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Sources & supplier listings
Seller lab-report checks and prices are available to members. Sign up free
Biology & proposed mechanism
The paper examined copper and zinc complex formation and cell responses after acetylation. Metal-binding behavior cannot establish clinical cognition or anxiety outcomes.
Questions worth asking
- Does acetylated Semax evidence validate NA-Semax Amidate?
- What material, population, and route were actually studied?
- The tested acetylated compound is related evidence, not confirmation of the full amidated variant or human cognitive benefit.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Does acetylated Semax evidence validate NA-Semax Amidate?
No. N-terminal acetylation and C-terminal amidation are separate modifications. The exact tested material must match before transferring findings.
Does the publication verify a supplier’s product?
No. The tested material and a commercial listing need separate identity and batch checks. A research-use disclaimer does not establish clinical suitability.
References & editorial record
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation.
